Advertisement
Journal of Biological Chemistry
Open access logo
Advanced searchSave search
Research Article| Volume 258, ISSUE 15, P9339-9343, August 10, 1983

Download started.

Ok

Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets.

Open AccessPublished:August 10, 1983DOI:https://doi.org/10.1016/S0021-9258(17)44672-2
Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets.
Previous ArticleIsolation and characterization of a third proteoglycan (PG-Lt) from chick embryo cartilage which contains disulfide-bonded collagenous polypeptide.
Next ArticleNonenzymatic glucosylation and glucose-dependent cross-linking of protein.
      This paper is only available as a PDF. To read, Please Download here.
      Human platelets incubated in the presence of 54 microM [1-14C]22:6 produced hydroxydocosahexaenoic acid (HDHE) at about half the rate with which 12-hydroxy-5,8,10,14-eicosatetraenoic acid is produced from [1-14C]arachidonic acid. More than 90% of the radioactivity in HDHE was distributed among two major isomers, 14-HDHE and 11-HDHE. The production of HDHEs was unaffected by indomethacin but completely inhibited by 5,8,11,14-heneicosatetraynoic acid, which suggests that the hydroxy fatty acids are produced by lipoxygenase. The proportions of HDHE isomers varied with the concentration of 22:6. The ratio 14-HDHE/11-HDHE was higher at 6.8 microM 22:6 than when platelets were incubated with 54 microM 22:6. It is suggested that the amounts of these isomers produced will depend both on the availability of 22:6 as well as by competition of this acid with other acids for lipoxygenase.

      REFERENCES

        • Sprecher H.
        • VanRollins M.
        • Sun F.
        • Wyche A.
        • Needleman P.
        J. Biol. Chem. 1982; 257: 3912-3918
        • LeDuc L.E.
        • Wyche A.
        • Sankarappa S.K.
        • Sprecher H.
        • Needleman P.
        Mol. Pharmacol. 1982; 19: 242-247
        • Needleman P.
        • Wyche A.
        • LeDuc L.
        • Sankarappa S.K.
        • Jakschik B.A.
        • Sprecher H.
        Prog. Lipid Res. 1982; 20: 415-422
        • Dyerberg J.
        • Bang H.O.
        • Stoffersen E.
        • Moncada S.
        • Vane J.R.
        Lancet. 1978; II: 117-119
        • Lands W.E.M.
        • LeTellier P.R.
        • Rome L.H.
        • Vanderhoek J.Y.
        Adv. Biosci. 1973; 9: 15-28
        • Needleman P.
        • Raz A.
        • Minkes M.S.
        • Ferrendelli J.A.
        • Sprecher H.
        Proc. Natl. Acad. Sci. U. S. A. 1979; 76: 944-948
        • Whittaker M.O.
        • Wyche A.
        • Fitzpatrick F.
        • Sprecher H.
        • Needleman P.
        Proc. Natl. Acad. Sci. U. S. A. 1979; 76: 5919-5923
        • Goodnight S.R.
        • Harris W.S.
        • Conner W.E.
        • Illingworth R.D.
        Arteriosclerosis. 1982; 2: 87-113
        • Siess W.
        • Scherer B.
        • Böhlig B.
        • Roth P.
        • Kurzmann I.
        • Weber P.C.
        Lancet. 1980; I: 441-444
        • Nugteren D.H.
        Biochim. Biophys. Acta. 1975; 380: 299-307
        • Sprecher H.
        Lipids. 1971; 6: 889-894
        • Minkes M.
        • Stanford N.
        • Chi M.M.-Y.
        • Roth G.J.
        • Raz A.
        • Needleman P.
        • Majerus P.W.
        J. Clin. Invest. 1979; 59: 449-454
        • Bills T.K.
        • Smith J.B.
        • Silver M.J.
        Biochim. Biophys. Acta. 1976; 424: 303-314
        • Hamberg M.
        • Samuelsson B.
        Proc. Natl. Acad. Sci. U. S. A. 1974; 71: 3400-3404
        • Chan H.W.S.
        • Levett G.
        Lipids. 1977; 12: 99-104
        • Diczfalusy V.
        • Falardeau P.
        • Hammarström S.
        FEBS Lett. 1977; 84: 271-274
        • Wilhelm T.E.
        • Sankarappa S.K.
        • VanRollins M.
        • Sprecher H.
        Prostaglandins. 1981; 21: 323-332
        • Sun F.F.
        • McGuire J.C.
        • Metzler C.M.
        Prog. Lipid Res. 1981; 20: 275-278
        • Falardeau P.
        • Hamberg M.
        • Samuelsson B.
        Biochim. Biophys. Acta. 1976; 441: 193-200
        • Hamberg M.
        Biochim. Biophys. Acta. 1980; 618: 389-398
        • Goetzl E.D.
        • Sun F.F.
        J. Exp. Med. 1979; 150: 406-411
        • Bryant R.W.
        • Bailey J.M.
        • Schewe T.
        • Rapoport S.M.
        J. Biol. Chem. 1982; 257: 6050-6055
        • Dutilh C.E.
        • Haddeman E.
        • Jouvenaz G.H.
        • Ten Hoor F.
        • Nugteren D.H.
        Lipids. 1979; 14: 241-246
        • Dutilh C.E.
        • Haddeman E.
        • Don J.A.
        • Ten Hoor F.
        Prostaglandins Med. 1981; 6: 111-126
        • Sams A.R.
        • Sprecher H.
        • Sankarappa S.K.
        • Needleman P.
        Adv. Prostaglandin Thromboxane Res. 1982; 9: 19-28

      Article info

      Publication history

      Published online: August 10, 1983

      Identification

      DOI: https://doi.org/10.1016/S0021-9258(17)44672-2

      Copyright

      © 1983 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.

      User license

      Creative Commons Attribution (CC BY 4.0) |
      How you can reuse Information Icon
      Creative Commons Attribution (CC BY 4.0)

      Permitted

      • Read, print & download
      • Redistribute or republish the final article
      • Text & data mine
      • Translate the article
      • Reuse portions or extracts from the article in other works
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      ASBMB  ASBMB  ASBMB  ASBMB

      ISSN 0021-9258
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX